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Hypomelanosis of Ito is the third most frequently oc­curring neurocutaneous disease, exceeded only by neurofibromatosis Type 1 and tuberous sclerosis, 
with an incidence of about 1 per 600–700 patients referred 
to a pediatric neurology service.6 Various chromosomal 
mosaics and X-autosome balanced translocations have 
been reported for most autosomal or sex chromosomes.8 
Hypomelanosis of Ito is characterized by uni- or bilateral 
macular cutaneous hypopigmented whorls, streaks, and 
patches along the lines of Blaschko, and it manifests dur­
ing childhood.10,15 Most patients with HI commonly have 
extracutaneous manifestations of the disease, including 
psychomotor retardation, autistic behavior, seizures, hy­
potonia, and macrocephaly.6 White matter alterations, mi­
grational abnormalities, hemispheric asymmetry, diffuse 
cerebral atrophy, brainstem atrophy, cerebellar atrophy, 
cerebellar hypoplasia, and agenesis or dysplasia of the 
corpus callosum, are often revealed on neuroimages in 
patients with HI.6 Musculoskeletal manifestations such as 
kyphoscoliosis, hypertelorism, body hemiatrophy, spina 
bifida, and syndactyly, and ocular system manifestations 
such as strabismus, myopia, chorioretinal atrophy, nystag­
mus, and microphthalmia are also characteristic features.8 
In addition, patients with HI sometimes manifest tumors; 
thus far, 4 cases of brain tumors associated with HI have 
been documented (Table 1).9,10,14,15 We report the second 
case of HI associated with choroid plexus papilloma; the 
chromosomal abnormality found in the present case dif­
fered from that in the first reported case.9,15
Case Report
History and Examination. This girl was born after 
an uneventful pregnancy at 38 weeks of gestation with a 
birth weight of 3886 g and a normal head circumference. 
Skin hypopigmentation along the lines of Blaschko (Fig. 
1A and B) and bilateral chorioretinal atrophy were noted 
at the age of 9 months. The patient showed developmen­
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tal delays and severe mental retardation; she was unable 
to stand up until she was 18 months old, and her speech 
was severely impaired. There was no family history of 
neuropsychomotor retardation, seizures, tumors, or pig­
mentation anomalies of the skin. At 6 years of age, she 
experienced complex partial seizures and was admitted 
to our hospital for examination of the brain lesions found 
on MRI.
The MRI studies showed bilateral lesions in the lat­
eral ventricles that had not been apparent 4 years earlier 
(Fig. 1C and D). There was no evidence of white mat­
ter alterations, brain atrophy or hypoplasia, hemispheric 
asymmetry, gray matter heterotopias, polymicrogyria and 
agenesis, or dysplasia of the corpus callosum. Magnetic 
resonance angiography and digital subtraction angiogra­
phy did not reveal vascular anomalies. On admission, the 
patient was alert and had no deficits in her cranial nerves. 
Although her muscle tonus was slightly hypotonic, no 
motor weakness was noted. Her sensory system seemed 
intact, although precise examinations of the sensory sys­
tem were impossible due to her severe mental retardation 
manifested, in part, through her minimal use of words 
and difficulty in communicating. Electroencephalogra­
phy revealed moderate alterations, mainly left parietal 
paroxysmal disturbances. On the basis of these clinical 
manifestations, her condition was diagnosed as HI.
Operation and Postoperative Course. Resection of the 
right lateral ventricle lesion was performed via a transcor­
tical approach. At the 40-month follow-up examination, 
there was no relapse of the tumor, and the tumor on the 
contralateral side was unchanged (Fig. 1E). The patient’s 
clinical status remained unchanged.
Diagnosis and Chromosomal Analyses of the Tumor. 
Pathological examination revealed that the tumor was a 
choroid plexus papilloma (WHO Grade I) (Fig. 2A). Im­
munohistochemical analysis revealed that the expression 
of tumor suppressor PTEN was negative in the tumor 
cells (Fig. 2B). The chromosomal analyses of the periph­
eral blood lymphocytes were normal, whereas the tumor 
cells revealed a large loss of heterozygosity: 46,XX,del(10)
(p?;q?) (Fig. 2C and D).
Discussion
Chromosomal analysis of the tumor cells in the pres­
ent case showed a large loss of heterozygosity on 10p 
and 10q. Immunohistochemical analysis revealed that 
the tumor cells were PTEN negative. In a previously re­
ported case of chromosome 10–associated HI, the patient 
presented with delayed neuropsychomotor development, 
abnormal electroencephalogram, and an arachnoid cyst 
in the temporal region.1 The patient showed chromosome 
mosaicism at 46,XY/46XY,del(10)(q.22.2–24.2), and this 
locus indicated inclusion of the PTEN (10q23.31) as well 
as pigmentary genes such as those associated with HPS1 
(10q24.2).12 The mutation of PTEN is known to have a pre­
dilection for the development of tumors as well as mental 
retardation, ataxia, seizures, and macrocephaly through 
changes in neuronal morphogenesis.2,13 Bannayan-Riley-
Ruvalcaba syndrome is a well-known PTEN deficiency–
Fig. 1. Features of the patient’s skin and brain MRI studies. A and B: Sharply demarcated, hypopigmented streaks are seen 
in a linear pattern on the neck and right arm. C: Coronal T1-weighted image obtained 4 years prior to the operation, demonstrat-
ing the absence of tumor. D: Coronal Gd-enhanced T1-weighted image showing bilateral intraventricular tumors. E: Coronal 
FLAIR image demonstrating total resection of the left ventricle tumor and no tumor recurrence. The right ventricle tumor remains 
unchanged.
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associated childhood syndrome.4 Clinical manifestation 
of Bannayan-Riley-Ruvalcaba syndrome is characterized 
by macrocephaly, intestinal hamartomatous polyps, lipo­
mas, pigmented maculae of the glans penis, downward 
slanting of the eyes, hypotonia, seizures, developmental 
delays, and mental retardation. These clinical manifesta­
tions also have some clinical overlap with those described 
by Almeida et al.1 and in the present case.
With respect to tumorigenesis, Rickert et al.7 report­
ed that the most frequently found chromosomal deletions 
among the 34 choroid plexus papillomas were loss of 
heterozygosity of 10q (56%) and 10p (47%). The tumor 
suppressor genes PTEN, MXI1 (10q25.2), and DMBT1 
(10q26.13) are known to be located on 10q (Fig. 2E). Al­
though identification of the responsible gene for the pres­
ent case would be difficult due to the large deletion, PTEN 
could be a candidate because of its many functions.2,13
The previously reported CNS tumors in patients with 
HI are summarized in Table 1; 2 benign9,15 and 2 malig­
nant cases10,14 have been reported. Among them, 2 cases 
exhibited chromosomal abnormalities.9,15 In the remain­
ing cases, the karyotype was normal in one case10 and 
the chromosomal analysis was not available in another 
case.14 One patient with HI and choroid plexus papilloma 
had a translocation at (X;17)(q13;p13).9,15 The authors pos­
tulated that FMR1L2 may play an important role in the 
pathogenesis of mental retardation and speculated that 
the 17p tumor-related locus (17p13.3) might activate p53. 
Fig. 2. Histological, immunohistological staining, and karyotype of the tumor. A: A well-maintained papillary structure and 
single-layered epithelium are seen. There are no mitotic cells (H & E). B: Immunohistochemical staining demonstrating the 
absence of PTEN expression in tumor cells. Note the vascular structures are stained positive with anti-PTEN antibody. C: 
Karyotype from the patient’s plexus papilloma showing a large loss of heterozygosity on chromosome 10. D: Enlarged view of 
chromosome 10. Large loss of heterozygosity is found on 10p (black arrow) and on 10q (white arrow). E: Schematic drawing of 
chromosome 10 with previously known tumor suppressor genes (PTEN, MXI1, and DMBT1) and pigmentary genes (HPS1 and 
HPS6) shown concomitantly. Bar = 100 μm (A) and 20 μm (B). 












 et al., 1993, &  
 Zajac et al., 1997
5, F CPP (WHO Grade I);  
 46,XX,t(X;17)(q12;p13)
gross motor retardation macrocephaly, nevoid  
 hypopigmentation  
 of retina
resection NA
Steiner et al., 1996 9, M medulloblastoma; 46,XY  
 (normal)
deafness hydrocephalus resection &  
 chemo
death at age 11 yrs
Xu et al., 2000 1, M meningeal rhabdomyosar- 
 coma; NA
regression of language, flac- 
 cid paresis of upper ex- 
 tremities, seizures, Bell palsy
hydrocephalus biopsy, RT & 
 chemo,  
 VPS 
improvement 1 mo  
 after RT
present case 6, F CPP (WHO Grade I);  
 46,XX,del(10)(p?;q?)
psychomotor retardation, sei- 
 zures, hypotonia
chorioretinal atrophy resection no change at 40  
 mos postsurgery
* chemo = chemotherapy; CPP = choroid plexus papilloma; NA = not available; RT = radiation therapy; VPS = ventriculoperitoneal shunt.
J Neurosurg: Pediatrics / Volume 10 / September 2012
Brain tumor associated with hypomelanosis of Ito
185
Interestingly, several studies have suggested that p53 and 
PTEN functionally affect each other.2
Although the pathogenesis of HI is unknown due to 
the many different karyotypic abnormalities involving 
different chromosomes,11 the described chromosomal 
varieties indicate that HI is a phenotype rather than a 
syndrome. In other words, HI is a cutaneous sign of mo­
saicism.5,12 Thus, irrespective of the loci of chromosomal 
abnormalities, it is important to note that de novo brain 
tumors may arise in patients with mosaic forms of skin 
disorders because they are manifestations of chromo­
somal imbalances.3 Additional experience with a greater 
number of patients is required to support this notion.
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